50 questions for delivering an exceptional healthcare brand experience

Zoe Bartley, Jenna Earl, Jiayi Chen|7th March 2019

A brand lives in the heart and mind of its audience as a sum of experiences. Every single engagement your brand has with its stakeholders is an opportunity to deliver a positive experience, while a sub-optimal experience can have a longterm impact on the perception of the brand.

One of the best ways to achieve this is through developing an effective multichannel plan, which can ensure you reach your customers using the right channel at the right time. This is especially poigniant in the era of declining rep access and rising customer preference for digital and omnichannel communications.

"That's why we have created this 50-question checklist to help you deliver an exceptional brand experience, based on what your stakeholders want and need when they need it"

However, we know that developing a multichannel campaign can be overwhelming. That's why we have created this 50-question checklist to help you deliver an exceptional brand experience, based on what your stakeholders want and need.

This checklist can be used in conjunction with our new 'Four Corners of Brand Experience' approach to brand strategy, which focuses on developing a deep understanding of your stakeholders to ensure you delivering a truely exceptional experience. 

 

Launch Excellence 2020

Blue Latitude Health|18th November 2019

In this publication, we explore what makes a successful pharma launch from developing insight that drives behaviour change to lean launches and multi-indication launches, as well as an evaluation of the CAR-T market.

read more

Precision medicine at Blue Latitude Health

Blue Latitude Health|7th November 2019

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.

read more

Understanding the evolving CAR-T market

Ditte Funding, Maria Katsarou, Natasha Cowan|1st November 2019

In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?

read more